Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
7.49
-0.13 (-1.71%)
Dec 5, 2025, 4:00 PM EST - Market closed
Wave Life Sciences Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Wave Life Sciences stock have an average target of 19.08, with a low estimate of 10 and a high estimate of 26. The average target predicts an increase of 154.74% from the current stock price of 7.49.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Wave Life Sciences stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 7 | 8 | 8 | 6 |
| Buy | 7 | 8 | 8 | 8 | 8 | 6 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 15 | 16 | 17 | 17 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $18 → $20 | Buy | Maintains | $18 → $20 | +167.02% | Nov 11, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $18 → $16 | Buy | Maintains | $18 → $16 | +113.62% | Nov 11, 2025 |
| Clear Street | Clear Street | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +193.72% | Oct 15, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $21 → $18 | Buy | Maintains | $21 → $18 | +140.32% | Sep 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +193.72% | Sep 3, 2025 |
Financial Forecast
Revenue This Year
42.22M
from 108.30M
Decreased by -61.02%
Revenue Next Year
55.35M
from 42.22M
Increased by 31.09%
EPS This Year
-1.21
from -0.70
EPS Next Year
-1.18
from -1.21
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 76.1M | 106.1M | ||||
| Avg | 42.2M | 55.3M | ||||
| Low | 32.4M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -29.7% | 151.2% | ||||
| Avg | -61.0% | 31.1% | ||||
| Low | -70.1% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.05 | -0.88 | ||||
| Avg | -1.21 | -1.18 | ||||
| Low | -1.33 | -1.59 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.